PPARGC1A and myotonic dystrophy type 1: Activation and subsequent nuclear migration of AMPK and peroxisome proliferator–activated receptor γ coactivator-1 α (PGC-1α) have been proposed to ameliorate RNA-mediated toxicity in DM1 mice (12–14, 20).